Delivery Order SPE2DB22D2214-SPE2DB24FS4ER
Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,143.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,603,841 units of epinephrine 0.3 mg auto-injector 2-packs. The $47,777.78 contract has a completion date of May 15, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,587.37 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,943,270 units of Epinephrine 0.3 mg auto-inject devices. This contract has an ultimate completion date of March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The delivery order was issued under an existing...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of epinephrine auto-injectors. The contract has a potential value of $1,960.08 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and the delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a $1,258.04 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,873,191 units of Epinephrine 0.3 mg auto-injectors. The delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,096.56 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,261,488 units of 0.3 mg epinephrine auto-injectors. The award is a standalone delivery order under DLA's primary contract vehicle with AmerisourceBergen, an indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. This IDC enables...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of epinephrine 0.3 mg auto-injectors. The contract has a completion date of February 12, 2024 and a potential value of $9,030.01. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,184,277 units of Epinephrine 0.3 mg auto-injectors. The $11,219.50 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,881,870 epinephrine 0.3 mg auto-injectors. The contract has a potential value of $1,205.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4ERDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,371.05 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 0.3 mg epinephrine auto-injectors. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has an ultimate completion date of April 3, 2024 and does not utilize any set-aside designations.
Generated 7/2/24, 3:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/2/24 |